News Results for Cello Group (CLL)

  • 11 Aug
    06:03
    Director Deals - Cello Health PLC (CLL)

    Julia Ralston, Executive Director, exercised 560,500 shares in the company on the 7th August 2020 at a price of 0.886200p. The Director now holds 1,140,905 shares. Story provided by...

  • 11 Aug
    06:03
    Director Deals - Cello Health PLC (CLL)

    Mark Bentley, Executive Director, exercised 355,000 shares in the company on the 7th August 2020 at a price of 0.100000p. The Director now holds 887,718 shares. Story provided by...

  • 11 Aug
    06:03
    Director Deals - Cello Health PLC (CLL)

    Mark Scott, Chief Executive Officer, exercised 701,250 shares in the company on the 7th August 2020 at a price of 0.100000p. The Director now holds 2,351,225 shares. Story provided by...

  • 11 Aug
    06:03
    Director Deals - Cello Health PLC (CLL)

    Stephen Highley, Executive Director, exercised 370,000 shares in the company on the 7th August 2020 at a price of 0.100000p. The Director now holds 2,596,304 shares. Story provided by...

  • 20 May
    09:27
    Cello Health expects further Covid-19 disruptions in Q2 following 'strong' growth in Q1

    Healthcare-focused advisory Cello Health Group said it had delivered 'strong' net revenue and profit growth for the first quarter, but said performance in its signal business was likely to be...

  • 08 Apr
    11:10
    Broker Forecast - Liberum Capital issues a broker note on Cello Group PLC

    Liberum Capital today reaffirms its hold investment rating on Cello Group PLC (LON:CLL) and cut its price target to 120p (from 125p). Story provided by StockMarketWire.com Broker Forecasts data...

  • 07 Apr
    14:44
    Cello Health replaces final dividend with smaller interim payment

    Healthcare consultancy Cello Health scraped its 2019 final dividend and replaced it with a smaller interim payout, citing uncertainty created by the Covid-19 crisis. The company had planned to pay...

  • 06 Feb
    09:01
    Cello Health pays £1.6m to Access Intelligence to settle net asset shortfall from sale of Pulsar

    Cello Health reached an agreement to pay £1.6m to Access Intelligence after net assets of Pulsar fell below an agreed target following completion of the sale. Under the terms of sale to Access...

  • 02 Oct
    09:44
    Cello Health sells Pulsar to Access Intelligence in deal valued at £4.5m

    Cello Health said it had sold Pulsar, the social media analytics software business, to Access Intelligence for £4.5m in a shares-only deal. The disposal of Pulsar would allow the group to ‘focus...

  • 30 Sep
    09:40
    Broker Forecast - Liberum Capital issues a broker note on Cello Group PLC

    Liberum Capital today initiates coverage of Cello Group PLC (LON:CLL) with a hold investment rating and price target of 135p. Story provided by StockMarketWire.com Broker Forecasts data provided...

  • 21 Aug
    08:20
    Broker Forecast - finnCap issues a broker note on Cello Group PLC

    finnCap today reaffirms its corporate investment rating on Cello Group PLC (LON:CLL) and raised its price target to 160p (from 145p). Story provided by StockMarketWire.com Broker Forecasts data...

  • 16 Aug
    07:16
    Cello Health acquires Innovative Science Solutions for up to $10.5m

    Cello Health said it had acquired Innovative Science Solutions for up to $10.5m. Under the terms of the deal, Cello paid an initial consideration of $6.4m in cash and agreed to pay a deferred...

  • 20 Jun
    17:25
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, exercised 450,000 shares in the company on the 20th June 2019 at a price of 10.00p. The Director now holds 1,914,575 shares. Story provided by...

  • 20 Jun
    17:25
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, sold post-exercise 265,500 shares in the company on the 20th June 2019 at a price of 126.60p. The Director now holds 1,649,975 shares. NOTE: Sold to meet tax...

  • 20 Jun
    17:25
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, exercised 220,000 shares in the company on the 20th June 2019 at a price of 10.00p. The Director now holds 662,518 shares. Story provided by StockMarketWire.com...

  • 20 Jun
    17:25
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, sold post-exercise 129,800 shares in the company on the 20th June 2019 at a price of 126.60p. The Director now holds 532,718 shares. NOTE: Sold to meet tax...

  • 20 Jun
    17:25
    Director Deals - Cello Group PLC (CLL)

    Stephen Highley, Executive Director, exercised 220,000 shares in the company on the 20th June 2019 at a price of 10.00p. The Director now holds 2,356,104 shares. Story provided by...

  • 20 Jun
    17:25
    Director Deals - Cello Group PLC (CLL)

    Stephen Highley, Executive Director, sold post-exercise 129,800 shares in the company on the 20th June 2019 at a price of 126.60p. The Director now holds 2,226,304 shares. NOTE: Sold to meet tax...

  • 08 May
    10:02
    Cello Health 'confident' of meeting market expectations after 'good' profit growth in Q1

    Cello Health said it was 'confident' of meeting full-year market expectations after posting 'good' like-for-like net revenue and headline profit in the first quarter. 'The Group has had a very...

  • 21 Mar
    08:38
    Cello Health hikes dividend as profits surge on strong growth at Cello Health segment

    Cello Health hiked its dividend after annual pre-tax profits jumped sharply amid a 'strong' performance from its Cello Health segment. For the year ended 31 December 2018, reported profit before...

  • 10 Oct
    09:00
    Director Deals - Cello Group PLC (CLL)

    Chris Jones, Non Executive Director, bought 22,726 shares in the company on the 9th October 2018 at a price of 132.00p. The Director now holds 22,726 shares representing 0.00% of the shares in...

  • 25 Sep
    13:40
    Director Deals - Cello Group PLC (CLL)

    Clifford Tompsett, Non Executive Director, bought 20,000 shares in the company on the 25th September 2018 at a price of 137.00p. The Director now holds 20,000 shares. Story provided by...

  • 24 Sep
    13:04
    Cello Health officially reclassified as healthcare company

    Advisory group Cello Health said it had been reclassified as a company in the healthcare sector, instead of one in the media sector. 'I welcome the re-classification of Cello's sector on the...

  • 22 Mar
    09:00
    Broker Forecast - finnCap issues a broker note on Cello Group PLC

    finnCap today reaffirms its corporate investment rating on Cello Group PLC (LON:CLL) and raised its price target to 145p (from 135p). Story provided by StockMarketWire.com Broker Forecasts data...

  • 18 Jan
    09:27
    Cello on track

    Cello Group expects results for the year ended 31 Dec to be in line with forecasts. The group said it traded well in 2017, with continued strong overall and like-for-like growth from Cello Health....

  • 22 Sep
    17:20
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, exercised 330,000 shares in the company on the 22nd September 2017 at a price of 10.00p. The Director now holds 1,350,175 shares. Story provided by...

  • 22 Sep
    17:20
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, sold post-exercise 194,700 shares in the company on the 22nd September 2017 at a price of 126.50p. The Director now holds 1,455,475 shares. NOTE: Sold to meet...

  • 22 Sep
    17:20
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, exercised 255,000 shares in the company on the 22nd September 2017 at a price of 10.00p. The Director now holds 592,968 shares. Story provided by...

  • 22 Sep
    17:20
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, sold post-exercise 150,450 shares in the company on the 22nd September 2017 at a price of 126.50p. The Director now holds 442,518 shares. NOTE: Sold to meet tax...

  • 22 Sep
    17:20
    Director Deals - Cello Group PLC (CLL)

    Stephen Highley, Executive Director, exercised 150,000 shares in the company on the 22nd September 2017 at a price of 10.00p. The Director now holds 2,224,604 shares. Story provided by...

  • 22 Sep
    17:20
    Director Deals - Cello Group PLC (CLL)

    Stephen Highley, Executive Director, sold post-exercise 88,500 shares in the company on the 22nd September 2017 at a price of 126.50p. The Director now holds 2,136,104 shares. NOTE: Sold to meet...

  • 20 Sep
    07:39
    Cello hikes divi after encouraging H1

    Cello's headline pre-tax profits rose by 8.0% to £4.6m in the six months to the end of June with continued rapid growth of Cello Health both organically and by acquisition. Gross profit increased...

  • 20 Sep
    07:03
    FLASH: Cello headline pre-tax profits up

    Story provided by StockMarketWire.com

  • 19 Jul
    07:23
    Cello on track

    Cello Group said it had a good first half with particularly strong overall and like-for-like growth from Cello Health. A pre-close update for the six months to the end of June said that with a...

  • 19 Jul
    07:09
    FLASH: Cello sees strong growth

    Story provided by StockMarketWire.com

  • 18 Jul
    07:27
    Cello acquires Advantage Healthcare

    Cello Group has acquired the assets of Advantage Healthcare. Cello said the proposed initial consideration for the acquisition was US$1.5 million, payable in cash. It said a further cash...

  • 18 Jul
    07:08
    FLASH: Cello acquires Advantage Healthcare

    Story provided by StockMarketWire.com

  • 09 May
    07:38
    Cello confident after good start

    Cello Group has had a good start to the year and the outlook at this relatively early stage is pleasing, shareholders at the annual general meeting today will be told. Chairman Allan Rich will...

  • 09 May
    07:06
    FLASH: Cello makes good start to year

    Story provided by StockMarketWire.com

  • 22 Mar
    13:30
    Broker Forecast - N+1 Singer issues a broker note on Cello Group PLC

    N+1 Singer today reaffirms its buy investment rating on Cello Group PLC (LON:CLL) and set its price target at 131p. Story provided by StockMarketWire.com

  • 22 Mar
    07:42
    Cello revenues rise

    Pharmaceutical and consumer strategic marketing group Cello's revenue rose 5.4% to £165.3m in the year to the end of December. Gross profit increased by 7.1% to £92.7m (2015: £86.5m) with...

  • 22 Mar
    07:14
    FLASH: Cello revenues rise

    Story provided by StockMarketWire.com

  • 01 Feb
    08:03
    Cello acquires Defined Health; raises £15m

    Cello Group has raised £15.0m, gross, through a placing of 15,463,919 new ordinary shares at £0.97 and will use part of the proceeds to acquire the assets of Defined Health which comprises Defined...

  • 01 Feb
    07:12
    FLASH: Cello acquires Defined Health; raises £15m

    Story provided by StockMarketWire.com

  • 19 Jan
    08:05
    Cello in line with market expectations

    Cello Group said it delivered an encouraging trading performance in the year to the end of December with gross profit and headline profits in line with consensus market expectations. Highlights:...

  • 19 Jan
    07:13
    FLASH: Cello in line with market expectations

    Story provided by StockMarketWire.com

  • 28 Sep
    10:10
    Broker Forecast - finnCap issues a broker note on Cello Group PLC

    finnCap today initiates coverage of Cello Group PLC (LON:CLL) with a buy investment rating and price target of 132p. Story provided by StockMarketWire.com

  • 20 Sep
    14:40
    Broker Forecast - N+1 Singer issues a broker note on Cello Group PLC

    N+1 Singer today reaffirms its buy investment rating on Cello Group PLC (LON:CLL) and raised its price target to 128p (from 127p). Story provided by StockMarketWire.com

  • 14 Sep
    07:45
    Cello revenues rise

    Healthcare focused strategic marketing group Cello's revenues rose 5.0% to £80.9m in the six months to the end of June. Gross profit rose by 4.0% to £43.5m with like-for-like gross profit...

  • 14 Sep
    07:12
    FLASH: Cello revenues rise

    Story provided by StockMarketWire.com

  • 26 Jul
    07:16
    Cello lyrical

    Cello had a good first half, with robust performances from the core of Cello Health and from Cello Signal. Accordingly, the board remains confident that the group will deliver a strong full year...

  • 20 May
    15:05
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, exercised 770,000 shares in the company on the 20th May 2016 at a price of 10.00p. The Director now holds 1,734,379 shares. Story provided by...

  • 20 May
    15:05
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, exercised 72,000 shares in the company on the 20th May 2016 at a price of 31.50p. The Director now holds 1,806,379 shares. Story provided by...

  • 20 May
    15:05
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, sold post-exercise 486,204 shares in the company on the 20th May 2016 at a price of 97.20p. The Director now holds 1,320,175 shares. NOTE: Sold to cover tax...

  • 20 May
    15:05
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, exercised 130,000 shares in the company on the 20th May 2016 at a price of 31.50p. The Director now holds 415,479 shares. Story provided by StockMarketWire.com...

  • 20 May
    15:05
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, exercised 130,000 shares in the company on the 20th May 2016 at a price of 31.50p. The Director now holds 415,479 shares. Story provided by StockMarketWire.com...

  • 20 May
    15:05
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, exercised 130,000 shares in the company on the 20th May 2016 at a price of 31.50p. The Director now holds 415,479 shares. Story provided by StockMarketWire.com...

  • 20 May
    15:05
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, exercised 130,000 shares in the company on the 20th May 2016 at a price of 31.50p. The Director now holds 415,479 shares. Story provided by StockMarketWire.com...

  • 16 May
    09:16
    Cello settles VAT dispute

    Cello Group has settled its dispute with HM Revenue & Customs over retrospective VAT and related penalties on historical fund raising activities delivered to charity clients by a division of...

  • 10 May
    15:44
    Cello resolutions passed at AGM

    Cello Group has confirmed that all resolutions proposed at its annual general meeting today were passed. At 3:44pm: (LON:CLL) Cello Group PLC share price was +2p at 94.5p Story provided by...

  • 10 May
    10:20
    Broker Forecast - Peel Hunt issues a broker note on Cello Group PLC

    Peel Hunt today reaffirms its buy investment rating on Cello Group PLC (LON:CLL) and set its price target at 130p. Story provided by StockMarketWire.com

  • 10 May
    07:55
    Cello board confident after good start

    Cello Group mas made a good start to the year with both Cello Health and Cello Signal in line with expectations, shareholders at the annual general meeting today will be told. Chairman Allan Rich...

  • 10 May
    07:08
    FLASH: Cello on track

    Story provided by StockMarketWire.com

  • 18 Apr
    08:55
    Cello Group schedules AGM

    Cello Group will hold its annual general meeting at the offices of Buchanan, 107 Cheapside, London, EC2V6DN, on 10 May at 12.30 p.m. At 8:55am: (LON:CLL) Cello Group PLC share price was 0p at...

  • 23 Mar
    10:30
    Broker Forecast - Peel Hunt issues a broker note on Cello Group PLC

    Peel Hunt today reaffirms its buy investment rating on Cello Group PLC (LON:CLL) and raised its price target to 130p (from 120p). Story provided by StockMarketWire.com

  • 17 Mar
    07:40
    Cello sees robust gross profit growth

    Cello Group reports a strong performance in the year to the end of December with robust gross profit growth. Revenue fell to GBP157.3m (2014: GBP169.9m) but gross profit rose by 7.0% to GBP86.7m...

  • 17 Mar
    07:07
    FLASH: Cello revenues fall

    Story provided by StockMarketWire.com

  • 27 Jan
    08:05
    Cello on track

    Cello, the health and consumer strategic marketing group, reports good trading for the year ended 31 December, with revenues and headline profits in line with consensus market expectations....

  • 27 Jan
    07:15
    FLASH: Cello on track

    Story provided by StockMarketWire.com

  • 16 Sep
    08:18
    Cello interim dividend up 5%

    Cello, the healthcare focused strategic marketing group, posts gross profits of £41.9m for the six months to the end of June - up 6.1% on last time. Revenue fell to £77.0m (2014: £78.3m) and...

  • 16 Sep
    07:07
    FLASH: Cello Group interim dividend up 5%

    Story provided by StockMarketWire.com

  • 21 Jul
    07:52
    Cello operating profits to be slightly lower

    Cello Group reports good trading for the first six months to 30 June, with strong headline revenue growth. But it says half year operating profits will be a little lower than last year due to...

  • 21 Jul
    07:03
    FLASH: Cello Group revenues up

    Story provided by StockMarketWire.com

  • 12 May
    07:46
    Cello continues to make good progress

    Cello Group continues to make good progress with strong headline revenue growth particularly in Cello Health, shareholders at the annual general meeting today will be told. Chairman Allan Rich...

  • 12 May
    07:09
    FLASH: Cello continues to make good progress

    Story provided by StockMarketWire.com

  • 20 Apr
    08:58
    Cello Group schedules AGM

    Cello Group will hold its annual general meeting at Buchanan, 107 Cheapside, London, EC2V 6DN, on 12 May at 12.30 p.m. At 8:58am: (LON:CLL) Cello Group PLC share price was 0p at 93.5p Story...

  • 19 Mar
    07:30
    Cello revenues up

    Cello - the pharmaceutical and consumer strategic marketing group - posts headline pre-tax profits of £9.4m for the year to the end of December, up 9.9% on last time. Revenue rose by 6.4% to...

  • 19 Mar
    07:03
    FLASH: Cello revenues up

    Story provided by StockMarketWire.com

  • 09 Feb
    13:54
    Cello update on potential VAT assessment

    Cello Group may face a wider than anticipated review by HMRC over VAT on items sold to charity clients. The group disclosed in its pre-close trading update on 22 January that one of Cello Signal's...

  • 22 Jan
    08:05
    Cello in line with consensus market expectations

    Health and consumer strategic marketing group Cello reports strong trading for the year ended 31 December, with revenues and headline profits in line with consensus market expectations. The group...

  • 22 Jan
    07:08
    FLASH: Cello in line with consensus market expectations

    Story provided by StockMarketWire.com

  • 09 Dec
    07:57
    Worldwide Promedica being acquired by Cello Group

    Cello Group (AIM: CLL), the healthcare and consumer strategic marketing group, has announced the acquisition of Worldwide Promedica, a San Francisco based market research firm serving...

  • 09 Dec
    07:15
    FLASH: Cello Group acquires Worldwide Promedica

    Story provided by StockMarketWire.com

  • 02 Oct
    12:15
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, bought 10,600 shares in the company on the 2nd October 2014 at a price of 92.00p. The Director now holds 964,379 shares. Story provided by...

  • 19 Sep
    16:35
    Director Deals - Cello Group PLC (CLL)

    Stephen Highley, Executive Director, exercised 52,000 shares in the company on the 18th September 2014 at a price of 10.00p. The Director now holds 2,098,868 shares. Story provided by...

  • 19 Sep
    16:35
    Director Deals - Cello Group PLC (CLL)

    Stephen Highley, Executive Director, exercised 52,000 shares in the company on the 18th September 2014 at a price of 10.00p. The Director now holds 2,098,868 shares. Story provided by...

  • 19 Sep
    16:35
    Director Deals - Cello Group PLC (CLL)

    Stephen Highley, Executive Director, sold post-exercise 51,979 shares in the company on the 18th September 2014 at a price of 91.00p. The Director now holds 2,046,889 shares. Story provided by...

  • 19 Sep
    16:30
    Director Deals - Cello Group PLC (CLL)

    Stephen Highley, Executive Director, exercised 10,000 shares in the company on the 18th September 2014 at a price of 42.00p. The Director now holds 2,046,868 shares. Story provided by...

  • 19 Sep
    16:30
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, exercised 130,000 shares in the company on the 18th September 2014 at a price of 10.00p. The Director now holds 368,500 shares. Story provided by...

  • 19 Sep
    16:30
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, sold post-exercise 83,021 shares in the company on the 18th September 2014 at a price of 91.00p. The Director now holds 285,479 shares. Story provided by...

  • 19 Sep
    16:30
    Director Deals - Cello Group PLC (CLL)

    Stephen Highley, Executive Director, exercised 36,000 shares in the company on the 18th September 2014 at a price of 10.00p. The Director now holds 2,036,868 shares. Story provided by...

  • 17 Sep
    09:52
    Cello headline pre-tax profits up

    Healthcare and consumer strategic marketing group Cello's headline pre-tax profits rose by 26.4% to £4.4m in the six months to the end of June - 28.9% up at constant currencies. Revenues were up...

  • 17 Jul
    08:13
    Cello reports robust trading

    Healthcare and consumer strategic marketing group Cello reports robust trading for the first six months to 30 June. Like-for-like gross profit growth (which excludes the impact of acquisitions)...

  • 17 Jul
    07:12
    FLASH: Cello Group reports robust trading

    Story provided by StockMarketWire.com

  • 18 Jun
    11:20
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, bought 10,000 shares in the company on the 17th June 2014 at a price of 87.00p. The Director now holds 953,779 shares. Story provided by StockMarketWire.com...

  • 03 Jun
    14:45
    Director Deals - Cello Group PLC (CLL)

    Mark Bentley, Financial Director, bought 8,500 shares in the company on the 3rd June 2014 at a price of 86.70p. The Director now holds 238,500 shares. Story provided by StockMarketWire.com...

  • 03 Jun
    14:45
    Director Deals - Cello Group PLC (CLL)

    Mark Scott, Chief Executive Officer, bought 15,000 shares in the company on the 3rd June 2014 at a price of 87.40p. The Director now holds 943,779 shares. Story provided by StockMarketWire.com...

  • 13 May
    13:02
    Cello resolutions passed at AGM

    Cello Group has confirmed that all resolutions put to shareholders at its annual general meeting today were passed. At 1:02pm: (LON:CLL) Cello Group PLC share price was +2.5p at 91.5p Story...

  • 13 May
    08:27
    Cello sees strong gross profit growth

    Cello Group has seen strong gross profit growth since the start of this year, shareholders at the annual general meeting later today will be told. Chairman Allan Rich will say: "The group has seen...

  • 13 May
    07:49
    Cello acquires iS Healthcare Dynamics

    Cello Group has acquired iS Healthcare Dynamics, an award-winning healthcare communications agency, specialising in medical communication services to UK, European and global healthcare clients....

Shares Magazine

Shares Magazine

Shares is the leading weekly publication for retail investors. It is packed with investment ideas, news and educational material to help build and run portfolios and get more from your money.

Don't miss the latest news! Sign up today

Investor Events

Investor Events

Shares puts on free Investor Events throughout the year across the country. They provide an opportunity for investors to learn more about companies on the stock market and hear from a range of investment experts including fund managers and Shares journalists.

Terms & Conditions | Privacy Policy | Cookies